Ocular Drug Delivery Technology Market

Ocular Drug Delivery Technology Market (Technology - Topical, Ocular Inserts (Non-Erodible and Erodible), Iontophoresis, Intraocular Implants (Biodegradable and Non-Biodegradable), and In Situ Gel & Punctal Plugs; Formulation Type - Suspension, Solution, Emulsion, Liposomes & Nanoparticles, and Ointments; Disease Type - Glaucoma, Diabetic Retinopathy, Macular Degeneration, Diabetic Macular Edema, and Cataract; End User - Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics, and Homecare Settings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global Ocular Drug Delivery Technology Market: Snapshot

Ocular drug delivery is related to the ophthalmic diseases which affect the eye or parts of eyes. According to the report by the World Health Organization (WHO), 1.3 bn people are suffering from vision impairment globally. Rising number of patients suffering from ophthalmic disorders and vision problems are boosting adoption of the ocular drug delivery and likely to fuel the growth of the global ocular drug delivery market.

Additionally, growing aging population globally are more susceptible to suffer from vision impairment is creating the need for effective treatments and drugs are boosting adoption of ocular drug delivery and likely to bolster growth of the global ocular drug delivery market.

Increasing investment in the research and development (R&D) activities in order to develop novel drugs are driving growth of the global ocular drug delivery technology market. Rising approvals from the US Food and Drugs Administration (FDA) are fuelling growth of the global market. Moreover, high number of pipeline drugs and other treatments are expected to offer lucrative opportunities in the global market for key players. Additionally, collaborative steps between vendors and hospitals are creating lucrative opportunities in the global ocular drug delivery technology market.

According to the report by TMR, the global ocular drug delivery technology market is expected to expand with a CAGR of 6.8% over the forecast period from 2017 to 2025 to attain value of US$18.12 bn by the end of forecast period from US$10.2 bn in 2016.

global ocular drug delivery technology market

Rising Number of Patients with Ophthalmic Disorders of to be Beneficial for Growth

On the basis of technology, the global ocular drug delivery technology market is segmented into topical, ocular inserts, intraocular implants, iontophoresis, and in situ gel & punctal plugs. The ocular inserts segment is further classified in to non-erodible and erodible. Intraocular implants segment is further classified into biodegradable and non-biodegradable. Of these,      topical segment dominated the global market in 2016, with more than 50% of the overall shares in the global market for ocular drug delivery technology. Thanks to these factors, the segment is expected to expand with 6.6% from 2017 to 2025.

On the basis of formulation type, the global infusion pumps market is segmented into suspension, solution, liposomes & nanoparticles, emulsion, and ointments. Based on the disease type, the global infusion pumps market is segmented into glaucoma, macular degeneration, diabetic retinopathy, diabetic macular edema, and cataract.

Growing Investments for Improvement of Healthcare Sector to Bolster Growth

On the basis of region, the global ocular drug delivery technology market is segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. Of these, North America is dominating the global market for ocular drug delivery technology and expected to continue its dominance over the forecast period tailed by Europe. Growth in the North America region is attributable to the demand for the targeted drug delivery systems. In 2016, the region accounted for massive 52.5% shares in the overall market. The European market accounted for 24% of the shares in the same year. However, Asia Pacific is expected to expand with higher CAGR over the forecast period thanks to the growing initiatives from the government for improving healthcare facilities.

Some of the prominent players operating in the ocular drug delivery technology market include OCULAR THERAPEUTIX, INC., Allergan, Plc., Alimera Sciences, EyeGate Pharma, and Valeant Pharmaceuticals International, Inc. the market has highly consolidated vendor landscape. The top three companies such as Santen Pharmaceutical Co., Ltd., Alimera Sciences, and Valeant Pharmaceuticals International, Inc. accounted for 50% of the shares in the overall market.

High Prevalence of Ophthalmic Disorders fuels Global Ocular Drug Delivery Technology Market

Ophthalmic diseases, which involve the eye or portions of the eye, are linked to ocular drug delivery.  As per the WHO (World Health Organization), around 1.3 billion people worldwide suffer from visual disability. The growing number of people suffering from vision-related issues and ophthalmic disorders is likely to better the acceptance of ocular drug delivery. This factor is expected to trigger development of the global ocular drug delivery technology market in the years to come.

In addition to that, the world's ageing population is increasing the need for successful medicines and medications, which is driving up the acceptance of ocular drug delivery. This factor is likely to support development of the global ocular drug delivery technology market.

Growth of the Market to Ride on the Back of Favorable Reimbursement Policies

The global ocular drug delivery technology market is predicted to rise due to many reasons, such as increased occurrence of ophthalmic disorders, rise in incidences of macular degeneration and  glaucoma incidence and . Furthermore, the industry is projected to be influenced by a rise in the number of approvals from federal regulations, favourable reimbursement policies, and increased investment to create innovative drug delivery systems. The need for ocular drug delivery technologies is expected to be fueled by the low bioavailability of drugs used in traditional ocular therapies.

Nonetheless, annoyance and pain in some patients, as well as dilution attributable to the stiffness of the implants, are likely to restrain global ocular drug delivery technology market in the years to come. Augmented demand for targeted drug delivery, particularly for posterior eye disorders, as well as increasing penetration of low molecular size particles, is likely to boost the scope of formulations of liposome and nanoparticle. Nanoparticles are also said to have longer ocular surface resistance time.

North America is set to maintain its dominance in the global ocular drug delivery technology market. The market in North America is expected to grow due to an emergence of a significant number of market players, high cost of ocular surgery and an increase in the number of instances of vision impairments.

The Global Ocular Drug Delivery Technology Market has been segmented as given below: 

by Technology

  • Topical
  • Ocular Insert
  • Erodible
  • Non-Erodible
  • Iontophoresis
  • Intraocular Implants
  • Biodegradable
  • Non-Biodegradable
  • In Situ Gel & Punctal Plugs
  • Others 

by Formulation Type

  • Solution
  • Suspension
  • Emulsion
  • Liposomes & Nanoparticles
  • Ointment

by Disease Type

  • Glaucoma
  • Macular Degeneration
  • Diabetic Retinopathy
  • Cataract
  • Diabetic Macular Edema
  • Dry Eye Syndrome
  • Others

by End user

  • Hospitals
  • Ambulatory Surgical centers
  • Ophthalmic Clinics
  • Homecare Settings

by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

    1. Preface
         1.1. Market Definition and Scope
         1.2. Market Segmentation
         1.3. Key Research Objectives
         1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Ocular Drug Delivery Disease Type Market

    4. Market Overview
         4.1. Introduction
                 4.1.1. Disease Type Definition
                 4.1.2. Industry Evolution / Developments
         4.2. Overview
         4.3. Key Market Indicators
                 4.3.1. Region/Country Specific
                 4.3.2. Product/Application/Disease Type Specific
                 4.3.3. Target Market Specific – Global Scenario
         4.4. Market Dynamics
                 4.4.1. Drivers
                 4.4.2. Restraints
                 4.4.3. Opportunity
         4.5. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, 2015–2025
         4.6. Ocular Drug Delivery Disease Type Market - Global Supply Demand Scenario
         4.7. Porter’s Five Force Analysis
         4.8. Market Outlook
         4.9. Ocular Drug Delivery Technology: Pipeline Analysis

    5. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type 
         5.1. Introduction & Definition
         5.2. Key Findings / Developments
         5.3. Key Trends
         5.4. Market Value Forecast By Disease Type , 2015–2025
                 5.4.1. Topical
                 5.4.2. Ocular Insert
                            5.4.2.1. Erodible
                            5.4.2.2. Non-Erodible
                 5.4.3. Iontophoresis
                 5.4.4. Intraocular Implant
                            5.4.4.1. Biodegradable 
                            5.4.4.2. Non-Biodegradable
                 5.4.5. In Situ Gel & Punctal Plug
                 5.4.6. Others
         5.5. Market Attractiveness By Disease Type 

    6. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Formulation Type 
         6.1. Introduction & Definition
         6.2. Key Findings / Developments
         6.3. Key Trends
         6.4. Market Value Forecast By Formulation Type , 2015–2025
                 6.4.1. Solution
                 6.4.2. Suspension
                 6.4.3. Emulsion
                 6.4.4. Liposomes & Nanoparticles
                 6.4.5. Ointments
         6.5. Market Attractiveness By Formulation Type 

    7. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type 
         7.1. Introduction & Definition
         7.2. Key Findings / Developments
         7.3. Key Trends
         7.4. Market Value Forecast By Disease Type , 2015–2025
                 7.4.1. Diabetic Retinopathy
                 7.4.2. Macular Degeneration
                 7.4.3. Cataract
                 7.4.4. Glaucoma
                 7.4.5. Diabetic Macular Edema
                 7.4.6. Dry Eye Syndrome
                 7.4.7. Others
         7.5. Market Attractiveness By Disease Type 

    8. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By End User 
         8.1. Introduction & Definition
         8.2. Key Findings / Developments
         8.3. Key Trends
         8.4. Market Value Forecast By End User , 2015–2025
                 8.4.1. Hospitals
                 8.4.2. Ambulatory Surgical Centers
                 8.4.3. Ophthalmic Clinics
                 8.4.4. Homecare Settings
         8.5. Market Attractiveness By End User 

    9. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Region
         9.1. Key Findings
         9.2. Policies and Regulations
         9.3. Market Value Forecast By Region
                 9.3.1. North America 
                 9.3.2. Europe 
                 9.3.3. Asia Pacific 
                 9.3.4. Latin America 
                 9.3.5. Middle East & Africa 
         9.4. Market Attractiveness By Country/Region

    10. North America Ocular Drug Delivery Disease Type Market Analysis and Forecast
         10.1. Introduction
                 10.1.1. Key Findings
                 10.1.2. Policies and Regulations
                 10.1.3. Price Trend Analysis
                 10.1.4. Key Trends
         10.2. Market Value Forecast By Disease Type , 2015–2025
                 10.2.1. Topical
                 10.2.2. Ocular Insert
                            10.2.2.1. Erodible
                            10.2.2.2. Non-Erodible
                 10.2.3. Iontophoresis
                 10.2.4. Intraocular Implant
                            10.2.4.1. Biodegradable 
                            10.2.4.2. Non-Biodegradable
                 10.2.5. In Situ Gel & Punctal Plug
                 10.2.6. Others
         10.3. Market Value Forecast By Formulation Type , 2015–2025
                 10.3.1. Solution
                 10.3.2. Suspension
                 10.3.3. Emulsion
                 10.3.4. Liposomes & Nanoparticles
                 10.3.5. Ointments
         10.4. Market Value Forecast By Disease Type , 2015–2025
                 10.4.1. Diabetic Retinopathy
                 10.4.2. Macular Degeneration
                 10.4.3. Cataract
                 10.4.4. Glaucoma
                 10.4.5. Diabetic Macular Edema
                 10.4.6. Dry Eye Syndrome
                 10.4.7. Others
         10.5. Market Value Forecast By End User , 2015–2025
                 10.5.1. Hospitals
                 10.5.2. Ambulatory Surgical Centers
                 10.5.3. Ophthalmic Clinics
                 10.5.4. Homecare Settings
         10.6. Market Value Forecast By Country , 2015–2025
                 10.6.1. U.S.
                 10.6.2. Canada
         10.7. Market Attractiveness Analysis 
                 10.7.1. By Disease Type 
                 10.7.2. By Formulation Type 
                 10.7.3. By Disease Type 
                 10.7.4. By End User 
                 10.7.5. By Country

    11. Europe Ocular Drug Delivery Disease Type Market Analysis and Forecast
         11.1. Introduction
                 11.1.1. Key Findings
                 11.1.2. Policies and Regulations
                 11.1.3. Price Trend Analysis
                 11.1.4. Key Trends
         11.2. Market Value Forecast By Disease Type , 2015–2025
                 11.2.1. Topical
                 11.2.2. Ocular Insert
                            11.2.2.1. Erodible
                            11.2.2.2. Non-Erodible
                 11.2.3. Iontophoresis
                 11.2.4. Intraocular Implant
                            11.2.4.1. Biodegradable 
                            11.2.4.2. Non-Biodegradable
                 11.2.5. In Situ Gel & Punctal Plug
                 11.2.6. Others
         11.3. Market Value Forecast By Formulation Type , 2015–2025
                 11.3.1. Solution
                 11.3.2. Suspension
                 11.3.3. Emulsion
                 11.3.4. Liposomes & Nanoparticles
                 11.3.5. Ointments
         11.4. Market Value Forecast By Disease Type , 2015–2025
                 11.4.1. Diabetic Retinopathy
                 11.4.2. Macular Degeneration
                 11.4.3. Cataract
                 11.4.4. Glaucoma
                 11.4.5. Diabetic Macular Edema
                 11.4.6. Dry Eye Syndrome
                 11.4.7. Others
         11.5. Market Value Forecast By End User , 2015–2025
                 11.5.1. Hospitals
                 11.5.2. Ambulatory Surgical Centers
                 11.5.3. Ophthalmic Clinics
                 11.5.4. Homecare Settings
         11.6. Market Value Forecast By Country , 2015–2025
                 11.6.1. U.K.
                 11.6.2. Germany
                 11.6.3. France
                 11.6.4. Italy
                 11.6.5. Russia
                 11.6.6. Spain
                 11.6.7. Rest of Europe
         11.7. Market Attractiveness Analysis 
                 11.7.1. By Disease Type 
                 11.7.2. By Formulation Type 
                 11.7.3. By Disease Type 
                 11.7.4. By End User 
                 11.7.5. By Country

    12. Asia Pacific Ocular Drug Delivery Disease Type Market Analysis and Forecast
         12.1. Introduction
                 12.1.1. Key Findings
                 12.1.2. Policies and Regulations
                 12.1.3. Price Trend Analysis
                 12.1.4. Key Trends
         12.2. Market Value Forecast By Disease Type , 2015–2025
                 12.2.1. Topical
                 12.2.2. Ocular Insert
                            12.2.2.1. Erodible
                            12.2.2.2. Non-Erodible
                 12.2.3. Iontophoresis
                 12.2.4. Intraocular Implant
                            12.2.4.1. Biodegradable 
                            12.2.4.2. Non-Biodegradable
                 12.2.5. In Situ Gel & Punctal Plug
                 12.2.6. Others
         12.3. Market Value Forecast By Formulation Type , 2015–2025
                 12.3.1. Solution
                 12.3.2. Suspension
                 12.3.3. Emulsion
                 12.3.4. Liposomes & Nanoparticles
                 12.3.5. Ointments
         12.4. Market Value Forecast By Disease Type , 2015–2025
                 12.4.1. Diabetic Retinopathy
                 12.4.2. Macular Degeneration
                 12.4.3. Cataract
                 12.4.4. Glaucoma
                 12.4.5. Diabetic Macular Edema
                 12.4.6. Dry Eye Syndrome
                 12.4.7. Others
         12.5. Market Value Forecast By End User , 2015–2025
                 12.5.1. Hospitals
                 12.5.2. Ambulatory Surgical Centers
                 12.5.3. Ophthalmic Clinics
                 12.5.4. Homecare Settings
         12.6. Market Value Forecast By Country , 2015–2025
                 12.6.1. China
                 12.6.2. Japan
                 12.6.3. India
                 12.6.4. Australia & New Zealand
                 12.6.5. Rest of Asia Pacific
         12.7. Market Attractiveness Analysis 
                 12.7.1. By Disease Type 
                 12.7.2. By Formulation Type 
                 12.7.3. By Disease Type 
                 12.7.4. By End User 
                 12.7.5. By Country

    13. Latin America Ocular Drug Delivery Disease Type Market Analysis and Forecast
         13.1. Introduction
                 13.1.1. Key Findings
                 13.1.2. Policies and Regulations
                 13.1.3. Price Trend Analysis
                 13.1.4. Key Trends
         13.2. Market Value Forecast By Disease Type , 2015–2025
                 13.2.1. Topical
                 13.2.2. Ocular Insert
                            13.2.2.1. Erodible
                            13.2.2.2. Non-Erodible
                 13.2.3. Iontophoresis
                 13.2.4. Intraocular Implant
                            13.2.4.1. Biodegradable 
                            13.2.4.2. Non-Biodegradable
                 13.2.5. In Situ Gel & Punctal Plug
                 13.2.6. Others
         13.3. Market Value Forecast By Formulation Type , 2015–2025
                 13.3.1. Solution
                 13.3.2. Suspension
                 13.3.3. Emulsion
                 13.3.4. Liposomes & Nanoparticles
                 13.3.5. Ointments
         13.4. Market Value Forecast By Disease Type , 2015–2025
                 13.4.1. Diabetic Retinopathy
                 13.4.2. Macular Degeneration
                 13.4.3. Cataract
                 13.4.4. Glaucoma
                 13.4.5. Diabetic Macular Edema
                 13.4.6. Dry Eye Syndrome
                 13.4.7. Others
         13.5. Market Value Forecast By End User , 2015–2025
                 13.5.1. Hospitals
                 13.5.2. Ambulatory Surgical Centers
                 13.5.3. Ophthalmic Clinics
                 13.5.4. Homecare Settings
         13.6. Market Value Forecast By Country , 2015–2025
                 13.6.1. Brazil
                 13.6.2. Mexico
                 13.6.3. Rest of Latin America
         13.7. Market Attractiveness Analysis 
                 13.7.1. By Disease Type 
                 13.7.2. By Formulation Type 
                 13.7.3. By Disease Type 
                 13.7.4. By End User 
                 13.7.5. By Country

    14. Middle East & Africa Ocular Drug Delivery Disease Type Market Analysis and Forecast
         14.1. Introduction
                 14.1.1. Key Findings
                 14.1.2. Policies and Regulations
                 14.1.3. Price Trend Analysis
                 14.1.4. Key Trends
         14.2. Market Value Forecast By Disease Type , 2015–2025
                 14.2.1. Topical
                 14.2.2. Ocular Insert
                            14.2.2.1. Erodible
                            14.2.2.2. Non-Erodible
                 14.2.3. Iontophoresis
                 14.2.4. Intraocular Implant
                            14.2.4.1. Biodegradable 
                            14.2.4.2. Non-Biodegradable
                 14.2.5. In Situ Gel & Punctal Plug
                 14.2.6. Others
         14.3. Market Value Forecast By Formulation Type , 2015–2025
                 14.3.1. Solution
                 14.3.2. Suspension
                 14.3.3. Emulsion
                 14.3.4. Liposomes & Nanoparticles
                 14.3.5. Ointments
         14.4. Market Value Forecast By Disease Type , 2015–2025
                 14.4.1. Diabetic Retinopathy
                 14.4.2. Macular Degeneration
                 14.4.3. Cataract
                 14.4.4. Glaucoma
                 14.4.5. Diabetic Macular Edema
                 14.4.6. Dry Eye Syndrome
                 14.4.7. Others
         14.5. Market Value Forecast By End User , 2015–2025
                 14.5.1. Hospitals
                 14.5.2. Ambulatory Surgical Centers
                 14.5.3. Ophthalmic Clinics
                 14.5.4. Homecare Settings
         14.6. Market Value Forecast By Country , 2015–2025
                 14.6.1. GCC Countries
                 14.6.2. South Africa
                 14.6.3. Rest of Middle East and Africa
         14.7. Market Attractiveness Analysis 
                 14.7.1. By Disease Type 
                 14.7.2. By Formulation Type 
                 14.7.3. By Disease Type 
                 14.7.4. By End User 
                 14.7.5. By Country

    15. Competition Landscape
         15.1. Market Player – Competition Matrix (By Tier and Size of companies)
         15.2. Market Share Analysis By Company (2015)
         15.3. Company Profiles 
                 15.3.1. OCULAR THERAPEUTIX, INC. 
                            15.3.1.1. Overview
                            15.3.1.2. Financials
                            15.3.1.3. Recent Developments
                            15.3.1.4. Strategy
                 15.3.2. Alimera Sciences
                            15.3.2.1. Overview
                            15.3.2.2. Financials
                            15.3.2.3. Recent Developments
                            15.3.2.4. Strategy
                 15.3.3. Allergan, Plc 
                            15.3.3.1. Overview
                            15.3.3.2. Financials
                            15.3.3.3. Recent Developments
                            15.3.3.4. Strategy
                 15.3.4. Valeant Pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)
                            15.3.4.1. Overview
                            15.3.4.2. Financials
                            15.3.4.3. Recent Developments
                            15.3.4.4. Strategy
                 15.3.5. EyeGate Pharma 
                            15.3.5.1. Overview
                            15.3.5.2. Financials
                            15.3.5.3. Recent Developments
                            15.3.5.4. Strategy
                 15.3.6. Envisia Therapeutics 
                            15.3.6.1. Overview
                            15.3.6.2. Financials
                            15.3.6.3. Recent Developments
                            15.3.6.4. Strategy
                 15.3.7. Clearside Biomedical, INC. 
                            15.3.7.1. Overview
                            15.3.7.2. Financials
                            15.3.7.3. Recent Developments
                            15.3.7.4. Strategy
                 15.3.8. Graybug Vision Inc. 
                            15.3.8.1. Overview
                            15.3.8.2. Financials
                            15.3.8.3. Recent Developments
                            15.3.8.4. Strategy
                 15.3.9. Santen Pharmaceutical Co., Ltd 
                            15.3.9.1. Overview
                            15.3.9.2. Financials
                            15.3.9.3. Recent Developments
                            15.3.9.4. Strategy
                 15.3.10. Taiwan Liposome Company, Ltd
                            15.3.10.1. Overview
                            15.3.10.2. Financials
                            15.3.10.3. Recent Developments
                            15.3.10.4. Strategy 

    List of Tables

    Table 01: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
    Table 02: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
    Table 03: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, Intraocular Implants, 2015–2025
    Table 04: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
    Table 05: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
    Table 06: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    Table 07: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Region, 2015–2025
    Table 08: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 09: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
    Table 10: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
    Table 11: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2015–2025
    Table 12: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
    Table 13: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
    Table 14: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
    Table 15: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 16: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
    Table 17: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
    Table 18: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2015–2025
    Table 19: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
    Table 20: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
    Table 21: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End Users, 2015–2025
    Table 22: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 23: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
    Table 24: Asia Pacific Ocular Drug Delivery Technology Market, by Ocular Inserts, Market Size (US$ Mn) Forecast, 2015–2025
    Table 25: Asia Pacific Ocular Drug Delivery Technology Market, by Intraocular Implants, Market Size (US$ Mn) Forecast, 2015–2025
    Table 26: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
    Table 27: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
    Table 28: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End User, 2015–2025
    Table 29: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 30: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
    Table 31: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
    Table 32: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2015–2025
    Table 33: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
    Table 34: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
    Table 35: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End Users, 2015–2025
    Table 36: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
    Table 37: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
    Table 38: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
    Table 39: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2015–2025
    Table 40: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
    Table 41: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
    Table 42: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025

    List of Figures

    Figure 1: Global Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast, 2015–2025
    Figure 2: Global Ocular Drug Delivery Technology Market Value Share, by Technology Type (2016)
    Figure 3: Global Ocular Drug Delivery Technology Market Value Share, by Formulations Type (2016)
    Figure 04: Global Ocular Drug Delivery Technology Market Value Share, by Disease Type (2016)
    Figure 05: Global Ocular Drug Delivery Technology Market Value Share, by Region (2016)
    Figure 06: Global Ocular Drug Delivery Technology Market Value Share, by End-user (2016)
    Figure 07: Global Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
    Figure 08: Global Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017–2025
    Figure 09: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Topical, 2015–2025
    Figure 10: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ocular Inserts, 2015–2025
    Figure 11: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Iontophoresis, 2015–2025
    Figure 12: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Intraocular Implants, 2015–2025
    Figure 13: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by In Situ Gel & Punctal Plugs, 2015–2025
    Figure 14: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Other Technology, 2015–2025
    Figure 15: Global Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
    Figure 16: Global Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017–2025
    Figure 17: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Suspension, 2015–2025
    Figure 18: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Solution, 2015–2025
    Figure 19: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Liposome & Nanoparticle, 2015–2025
    Figure 20: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Emulsion, 2015–2025
    Figure 21: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Ointment, 2015–2025
    Figure 22: Global Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
    Figure 23: Global Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017–2025
    Figure 24: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Glaucoma, 2015–2025
    Figure 25: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diabetic Retinopathy, 2015–2025
    Figure 26: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Dry Eye Syndrome, 2015–2025
    Figure 27: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Macular Degeneration, 2015–2025
    Figure 28: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diabetic Macular Edema, 2015–2025
    Figure 29: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cataract, 2015–2025
    Figure 30: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015–2025
    Figure 31: Global Ocular Drug Delivery Technology Market Value Share, by End-user, 2017 and 2025
    Figure 32: Global Ocular Drug Delivery Technology Market Attractiveness, by End-user, 2017–2025
    Figure 33: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2015–2025
    Figure 34: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by ASCs, 2015–2025
    Figure 35: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ophthalmic Clinics, 2015–2025
    Figure 36: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Home Care Settings, 2015–2025
    Figure 37: Global Ocular Drug Delivery Technology Market Value Share, by Region, 2017 and 2025 
    Figure 38: Global Ocular Drug Delivery Technology Market Attractiveness, by Region, 2017–2025
    Figure 39: North America Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
    Figure 40: North America Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
    Figure 41: North America Ocular Drug Delivery Technology Market Attractiveness, 2017–2025
    Figure 42: North America Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
    Figure 43: North America Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017–2025
    Figure 44: North America Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
    Figure 45: North America Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017–2025
    Figure 46: North America Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
    Figure 47: North America Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017–2025
    Figure 48: North America Ocular Drug Delivery Technology Market Value Share, by End-user, 2017 and 2025
    Figure 49: North America Ocular Drug Delivery Technology Market Attractiveness, by End-user, 2017–2025
    Figure 50: Europe Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
    Figure 51: Europe Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
    Figure 52: Europe Ocular Drug Delivery Technology Market Attractiveness, by Country, 2017–2025
    Figure 53: Europe Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
    Figure 54: Europe Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017-2025
    Figure 55: Europe Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
    Figure 56: Europe Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017-2025
    Figure 57: Europe Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
    Figure 58: Europe Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017-2025
    Figure 59: Europe Ocular Drug Delivery Technology Market Value Share, by End Users, 2017 and 2025
    Figure 60: Europe Ocular Drug Delivery Technology Market Attractiveness, by End Users, 2017-2025
    Figure 61: Asia Pacific Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
    Figure 62: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
    Figure 63: Asia Pacific Ocular Drug Delivery Technology, Market Attractiveness, by Country, 2017–2025
    Figure 64: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
    Figure 65: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017-2025
    Figure 66: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
    Figure 67: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017-2025
    Figure 68: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
    Figure 69: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017-2025
    Figure 70: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by End User, 2017 and 2025
    Figure 71: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by End User, 2017–2025
    Figure 72: Latin America Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
    Figure 73: Latin America Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
    Figure 74: Latin America Ocular Drug Delivery Technology, Market Attractiveness, by Country, 2017–2025
    Figure 75: Latin America Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
    Figure 76: Latin America Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017-2025
    Figure 77: Latin America Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
    Figure 78: Latin America Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017–2025
    Figure 79: Latin America Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
    Figure 80: Latin America Ocular Drug Delivery Technology  Market Attractiveness, by Disease Type, 2017-2025
    Figure 81: Latin America Ocular Drug Delivery Technology Market Value Share, by End Users, 2017 and 2025
    Figure 82: Latin America Ocular Drug Delivery Technology Market Attractiveness, by End Users, 2017–2025
    Figure 83: Middle East & Africa Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
    Figure 84: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
    Figure 85: Middle East & Africa Ocular Drug Delivery Technology, Market Attractiveness, by Country, 2017–2025
    Figure 86: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
    Figure 87: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017–2025
    Figure 88: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
    Figure 89: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017-2025
    Figure 90: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
    Figure 91: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017–2025
    Figure 92: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by End-user, 2017 and 2025
    Figure 93: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by End-user, 2017–2025
    Figure 94: Global Ocular Drug Delivery Technology  Market Share, by Company, 2016

Copyright © Transparency Market Research, Inc. All Rights reserved